3.0-T functional brain imaging: A 5-year experience;L'imaging funzionale cerebrale 3,0 T: L'esperienza di 5 anni

Radiologia Medica

Volumn 112, Issue 1, 2007, Pages 97-112

  Scarabino, T ^a,b,c,j   Giannatempo, G M ^b   Popolizio, T ^b   Tosetti, M ^d   D'Alesio, V ^b   Esposito, F ^e   Di Salle, F ^f   Di Costanzo, A ^g   Bertolino, A ^h   Maggialetti, A ^a   Salvolini, U ⁱ  

^a Ospedale L Bonomo   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c Fondazione S Raffaele G Giglio   (Italy)

^d DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f UNIVERSITY OF PISA   (Italy)

^g Università del MoliseCampobasso   (Italy)

^h UNIVERSITY OF BARI   (Italy)

ⁱ UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^j NONE   (Italy)

more..

Author keywords

fMRI; High field; Magnetic resonance

Indexed keywords

CONTRAST MEDIUM; OXYGEN;

ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; BRAIN PERFUSION; DIAGNOSTIC PROCEDURE; DIFFUSION; DIFFUSION TENSOR IMAGING; DIGITAL IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; IMAGE ENHANCEMENT; MAGNETISM; METABOLITE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN BLOOD LEVEL; PERSONAL EXPERIENCE; RELIABILITY; SENSITIVITY ANALYSIS; SIGNAL NOISE RATIO; SPECTROSCOPY;

ARTIFACTS; ASPARTIC ACID; BRAIN; BRAIN DISEASES; BRAIN NEOPLASMS; CEREBRAL ARTERIES; CEREBRAL CORTEX; CHOLINE; CONTRAST MEDIA; CREATINE; DIFFUSION MAGNETIC RESONANCE IMAGING; GAMMA-AMINOBUTYRIC ACID; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN; TIME FACTORS;

EID: 33847614737     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-007-0124-x     Document Type: Article

References (52)

1. Scarabino T, Giannatempo GM, Nemore F et al (2003) RM 3,0 Tesla. II parte: L'imaging morfo-funzionale cerebrale. Radiol Med 105:150-161
2. Scarabino T, Nemore F, Giannatempo GM et al (2003) Risonanza Magnetica 3,0 Tesla. Riv Neurorad 16:314-315
3. Scarabino T, Nemore F, Giannatempo GM et al (2003) 3,0 T Magnetic Resonance in neuroradiology. Eur J Radiol 48:154-164
4. Di Costanzo A, Trojsi F, Giannatempo GM et al ( 2003) High-field proton MRS of human brain. Eur J Radiol 48:146-153
5. Polonara G, Scarabino T, Salvolini U (2003) Basics and new frontiers of MR spectroscopy with high Tesla. Riv Neurorad 16:144-148
6. Frayne R, Giidyear BG, Dickhoff P et al (2003) Magnetic resonance imaging at 3,0 tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 38:385-402
7. Takahashi M, Uematsu H, Hatabu H (2003) MR imaging at high magnetic fields. Eur J Radiol 46:45-52
8. Gruber S, Mlynarik V, Moser E (2003) High-resolution 3 D proton spectroscopic imaging of the human brain at 3 T: SNR issue and application for anatomy-matched voxel sizes. Magn Reson Med 49:299-306
9. Bielicki G, Chassain C, Renou JP et al (2004) Brain GABA editing by localized in vivo 1H magnetic resonance spectroscopy. NMR Biomed 17:60-68
10. Schubert F, Gallinat J, Seifert F et al (2004) Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3,0 tesla. Neuroimage 21:1762-1771
11. Barker PB, Hearshen DO, Boska MD (2001) Single-voxel proton MRS of the human brain at 1,5 T and 3,0 T. Magn Reson Med 45:765-769
12. Gonen O, Gruber S, Li BS et al (2001) Multivoxel 3D proton spectroscopy in the brain at 1,5 T versus 3,0 T: signal-to-noise ratio and resolution comparison. Am J Neuroradiol 22:1727-1731
13. Mlynarik V, Gruber S, Moser E (2001) Proton T1 and T2 relaxation times of human brain metabolities at 3,0 T. NMR Biomed 14:325-331
14. Traber F, Block W, Lamerichs R et al (2004) 1H metabolite relaxation times at 3,0 tesla: measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation. J Magn Reson Imaging 19:537-545
15. Hunskhe S, Moseley ME, Stoeter P et al (2001) Diffusion-tensor MR imaging at 1,5 and 3,0 T: initial observation. Radiology 221:550-556
16. Kuhl CK, Textor HJ, Simon B et al (2002) Determine optimum b-value for diffusion imaging of acute ischemic stroke at high magnetic fields (3,0 T). Radiology 225:278
17. Price SJ, Burnet NG, Donovan T et al (2003) Diffusion tensor imaging of brain tumours at 3 T: a potential tool for assessing while matter tract invasion. Clin Radiol 58:455-462
18. Jaermann T, Crelier G, Pruessmann KP et al (2004) SENSE-DTI at 3 T. Magn Reson Med 51:230-236
19. Naganawa S, Koshikawa T, Kawai H et al (2004) Optimization of diffusion-tensor MR imaging data acquisition for brain fiber tracking using parallel imaging at 3 T. Eur Radiol 14:234-238
20. Cheryauka AB, Lee JN, Samsonov AA et al (2004) MRI diffusion tensor reconstruction with PROPELLER data acquisition. Magn Reson Imaging 22:139-148
21. Xu D, Henry RG, Mukherjiee P et al (2004) Single-shot fast spin-echo diffusion tensor imaging of the brain and spine with head and phase array coils at 1,5 T and 3,0 T. Magn Reson Imaging 22:751-759
22. Scarabino T, Giannatempo GM, Pollice S et al (2004) 3,0 T perfusion MR imaging. Riv Neurorad 17:807-812
23. Manka C, Traber F, Gieseke J et al (2005) Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3,0 T: feasibility and contrast agent dose. Radiology 234:869-877
24. Wang J, Alsop DC, Li L et al (2002) Comparison of quantitative perfusion imaging using arterial spin labeling at 1,5 and 4.0 Tesla. Magn Reson Med 48:242-254
25. Kruger G, Kastrup A, Glover GH (2001) Neuroimaging at 1,5 T and 3,0 T: comparison of oxygenation-sensitive magnetic resonance imaging. Magn Reson Med 45:595-604
26. Heiland S, Kreibich W, Reith W et al (1998) Comparison of echo-planar sequences for perfusion-weighted MRI: which is best? Neuroradiology 40:216-221
27. Keston P, Murray AD, Jackson A (2003) Cerebral perfusion imaging using contrast-enhanced MRI. Clin Radiol 58:505-513
28. Hillis AE, Wityk RJ, Beauchamp NJ et al (2004) Perfusion-weighted MRI as a marker of response to treatment in acute and subacute stroke. Neuroradiology 46:31-39
29. Benner T, Reimer P, Erb G et al (2000) Cerebral MR perfusion imaging: first clinical application of a 1 M gadolinium chelate (Gadovist 1.0) in a double-blinded randomized dose-finding study. J Magn Reson Imaging 12:371-380
30. Lupo JM, Lee MC, Han ET et al (2005) Feasibility of dynamic susceptibility-weighted perfusion MRI at 3T using a standard head coil and 8-channel phased-array coil with and without SENSE reconstruction. Proc Intl Soc Mag Reson Med 13:741
31. Larsson H.B, Berg HK, Vangberg T et al (2005) Measurement of CBF and PS product in brain tumor patients using T1 w dynamic contrast enhanced MRI at 3 tesla. Proc Intl Soc Mag Reson Med 13:2082
32. Morgan PS, George MS, Kozel FA et al (2005) Dynamic Contrast Enhanced Whole Brain Perfusion using a Rapid 3D T1-weighted Sequence at 1,5T and 3T. Proc Intl Soc Mag Reson Med 13:1257
33. Thilmann O, Larsson EM, Bjorkman-Burtscher IM et al (2004) Effects of echo time variation on perfusion assessment using dynamic susceptibility contrast MR imaging at 3 Tesla. Magn Reson Imaging 22:929-935
34. Stollberger R, Fazekas F (2004) Improved perfusion and tracer kinetic imaging using parallel imaging. Top Magn Reson Imaging 15:245-254
35. Holmes TM, Petrella JR, Provenzale JM (2004) Distinction between cerebral abscesses and high-grade neoplasms by dynamic susceptibility contrast perfusion MRI. AJR Am J Roentgenol 183:1247-1252
36. Shin W, Sakaie K, Cashen TA et al (2005) High Field (3,0T) CBF Imaging using Spin-echo EPI and Parallel Imaging. Proc Intl Soc Mag Reson Med 13:1124
37. Zaharchuk G, Ledden PJ, Kwong KK et al (1999) Multislice perfusion and perfusion territory imaging in humans with separate label and image coils. Magn Reson Med 41:1093-1098
38. Werner R, Alfke K, Schaeffter T et al (2004) Spatially selective perfusion imaging applying continuous arterial spin labeling. Proc Intl Soc Mag Reson Med 12:715
39. Song HK, Zhang Y, Wolf RL et al (2004) Unilateral labeling PASL technique for vascular territory perfusion imaging. Proc Intl Soc Mag Reson Med 12:1358
40. Hendrikse J, van Raamt AF, van der Graaf Y et al (2005) Distribution of cerebral blood flow in the circle of Willis. Radiology 235:184-189
41. Hendrikse J, van der Grond J, Lu H et al (2004) Flow territory mapping of the cerebral arteries with regional perfusion MRI. Stroke 35:882-887
42. Hendrikse J, van Osch MJ, van der Zwan A et al (2005) Altered flow territories after extracranial to intracranial bypass surgery: clinical implementation of selective arterial spin labeling MRI. Proc Intl Soc Mag Reson Med 13:1137
43. van Laar PJ, Hendrikse J, Golay X et al (2005) In-vivo flow territory mapping of major brain feeding arteries: a population study with selective arterial spin labeling MRI. Proc Intl Soc Mag Reson Med 13:1134
44. Ogawa S, Lee T-M, Kay AR et al (1990) Brain Magnetic Resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci USA 87:9868-9872
45. Gati JS, Menon RS, Rutt BK (1999) Field strength dependence of functional MRI signals. In: Moonen CTW, Bandettini PA (eds) Functional MRI. Springer-Verlag, Heidelberg, pp 277-282
46. Ogawa S, Menon RS, Tank DW et al (1993) Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model. Biophys J 64:803-812
47. Gati JS, Menon RS, Ugurbil K et al (1997) Experimental determination of the BOLD field strength dependence in vessels and tissue. Magn Reson Med 38:296-302
48. Kim D-S, Garwood M (2003) High field magnetic resonance techniques for brain research. Curr Opin Neurobiol 13:612-619
49. Di Salle F, Esposito F, Elefante A et al (2003) High field functional MRI. Eur J Radiol 48:138-145
50. Chen W, Ugurbil K (1999) High spatial resolution functional magnetic resonance imaging at very-high-magnetic field. Top Magn Reson Imaging 10:63-78
51. Thulborn KR (1999) Clinical rationale for very-high-field (3,0 Tesla) functional magnetic resonance imaging. Top Magn Reson Imaging 10:37-50
52. Thulborn KR, Chang SY, Shen GX et al (1997) High resolution echo-planar imaging of human cortex at 3,0T. NMR Biomed 10:183